Preparation of horse polyvalent antiserum against rhodococcus equi and evaluation of its therapeutic and prophylactic efficacy / Shimaa Ahmed Abdelbaki ; Supervised Rafik Tawfik Mohamed Soliman , Mohamed Youssef Salah Mattok , George Abdelmalak Habib
Material type:
- تحضير مصل خيول متعدد ضد بكتريا الرودوكوكس اكواى و تقييم قدرته العلاجية و الوقائية [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.10.10.M.Sc.2018.Sh.P (Browse shelf(Opens below)) | Not for loan | 01010110077638000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.10.10.M.Sc.2018.Sh.P (Browse shelf(Opens below)) | 77638.CD | Not for loan | 01020110077638000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - Cairo University - Faculty of Veterinary Medicine - Department of Microbiology
Rhodococcus equi, a Gram-positive facultative intracellular pathogen, is among the most widely recognized causes of pneumonia in foals. Several antimicrobial drugs are effective against R. equi in vitro; however, many of these agents are ineffective in vivo because of the capability of R. equi to survive and replicates in macrophages. The present study aimed to prepare R. equi-specific hyperimmune horse antiserum and to evaluate its therapeutic and prophylactic efficacy against R. equi infection. Four horses were immunized with a locally prepared formalin inactivated R. equi vaccine adjuvanted with mineral oil. Each of these horses was immunized with 3 doses of the prepared vaccine (3ml/ dose) at 2 weeks intervals. One week after the last vaccination dose, serum from immunized horses was collected by plasmapheresis. The measured titer of R. equi specific antibodies reached to 104 ELISA units/ml after 2 weeks from the primary immunization and up to 105 ELISA units/ml one week after the third immunization dose
Issued also as CD
There are no comments on this title.